William Pao

  • Vanderbilt University

    VU study identifies new gene fusions in melanoma

    Cancer researchers, led by investigators at Vanderbilt-Ingram Cancer Center, have identified two novel gene fusions in melanoma that may be responsive to existing cancer therapies. Melanoma is the most deadly form of skin cancer. Read More

    Dec. 19, 2013

  • Vanderbilt University

    Probing mutant EGF receptor regulation

    Understanding the regulation of mutant EGF receptors commonly found in lung cancers could lead to new targeted therapies. Read More

    Oct. 10, 2013

  • Deciphering DNA code

    VU study identifies DNA changes in drug-resistant cancer cells

    Vanderbilt investigators have combined next-generation sequencing technologies and bioinformatics analyses to screen for genome-wide genetic mutations associated with drug resistance in a series of lung cancer cell lines. Read More

    Sep. 12, 2013

  • Vanderbilt University

    Vanderbilt planning for the future

    An executive committee has been named and will meet regularly this summer to develop a framework of ideas to guide a university-wide academic strategic planning process that will set the course for Vanderbilt’s future. Read More

    Jul. 5, 2013

  • Vanderbilt University

    Foundation lauds graduate student’s melanoma research

    Katherine Hutchinson, a third-year graduate student in Cancer Biology at Vanderbilt University, has won a $10,000 Research Scholar Award from the Joanna M. Nicolay Melanoma Foundation. Read More

    Mar. 28, 2013

  • Vanderbilt University

    New endowed chair holders recognized

    Cancer researchers, led by investigators at Vanderbilt-Ingram Cancer Center, have identified two novel gene fusions in melanoma that may be responsive to existing cancer therapies. Melanoma is the most deadly form of skin cancer. From left, Jeffrey Sosman, M.D., doctoral candidate Katherine Hutchinson and William Pao, M.D.,… Read More

    Dec. 20, 2012

  • Nine Vanderbilt faculty members named to endowed chairs were recognized for outstanding academic achievement during a Dec. 12 ceremony. (Steve Green/Vanderbilt)

    Nine faculty honored at endowed chair celebration

    Nine Vanderbilt University faculty members named to endowed chairs were honored for outstanding academic achievements Dec. 12 during a celebration at the Student Life Center. Read More

    Dec. 13, 2012

  • Vanderbilt University

    Photo: Lung Cancer Partnership

    Cancer researchers, led by investigators at Vanderbilt-Ingram Cancer Center, have identified two novel gene fusions in melanoma that may be responsive to existing cancer therapies. Melanoma is the most deadly form of skin cancer. From left, Jeffrey Sosman, M.D., doctoral candidate Katherine Hutchinson and William Pao, M.D.,… Read More

    Sep. 27, 2012

  • Vanderbilt University

    HER2 may impact lung cancer therapy

    A protein associated with aggressive breast cancers may also influence resistance of lung cancer to targeted therapies. Read More

    Sep. 21, 2012

  • Vanderbilt University

    Stand Up to Cancer TV broadcast airs Sept. 7

    Cancer researchers, led by investigators at Vanderbilt-Ingram Cancer Center, have identified two novel gene fusions in melanoma that may be responsive to existing cancer therapies. Melanoma is the most deadly form of skin cancer. From left, Jeffrey Sosman, M.D., doctoral candidate Katherine Hutchinson and William Pao, M.D.,… Read More

    Aug. 30, 2012

  • genetic sequence

    Vanderbilt cancer investigators win two national GE cancer research grants

    Vanderbilt-Ingram Cancer Center investigators have won two of the five global innovation grants awarded by the “GE Healthymagination Cancer Challenge.” Read More

    Mar. 28, 2012

  • Jeff Sosman

    Jeffrey Sosman named to melanoma research ‘Dream Team’

    Cancer researchers, led by investigators at Vanderbilt-Ingram Cancer Center, have identified two novel gene fusions in melanoma that may be responsive to existing cancer therapies. Melanoma is the most deadly form of skin cancer. From left, Jeffrey Sosman, M.D., doctoral candidate Katherine Hutchinson and William Pao, M.D.,… Read More

    Dec. 15, 2011

  • Vanderbilt University

    Stanley Cohen’s Nobel Prize: 25 years of progress

    Twenty-five years after he received the Nobel Prize, Stanley Cohen’s discovery of epidermal growth factor continues to transform medicine. Read More

    Dec. 9, 2011

  • Vanderbilt University

    Kudos

    Cancer researchers, led by investigators at Vanderbilt-Ingram Cancer Center, have identified two novel gene fusions in melanoma that may be responsive to existing cancer therapies. Melanoma is the most deadly form of skin cancer. From left, Jeffrey Sosman, M.D., doctoral candidate Katherine Hutchinson and William Pao, M.D.,… Read More

    Oct. 3, 2011

  • Vanderbilt University

    Study suggests new lung cancer therapy schedule

    A new lung cancer study led by Vanderbilt-Ingram Cancer Center investigators found that various non-small cell lung cancer cells grow at different rates, which may explain why some tumors become resistant to anti-cancer drugs faster than others. Read More

    Aug. 10, 2011

  • Vanderbilt University

    Vanderbilt: Laboratory for health care reform

    Cancer researchers, led by investigators at Vanderbilt-Ingram Cancer Center, have identified two novel gene fusions in melanoma that may be responsive to existing cancer therapies. Melanoma is the most deadly form of skin cancer. From left, Jeffrey Sosman, M.D., doctoral candidate Katherine Hutchinson and William Pao, M.D.,… Read More

    Apr. 15, 2011

  • (iStock Photo)

    Vanderbilt-Ingram Cancer Center launches online genetic research tool

    A new online tool enables cancer patients and researchers to track the latest developments in personalized cancer medicine and connect with clinical research trials. Read More

    Mar. 3, 2011

  • Vanderbilt University

    VUCast: New weapon in cancer war

    Cancer researchers, led by investigators at Vanderbilt-Ingram Cancer Center, have identified two novel gene fusions in melanoma that may be responsive to existing cancer therapies. Melanoma is the most deadly form of skin cancer. From left, Jeffrey Sosman, M.D., doctoral candidate Katherine Hutchinson and William Pao, M.D.,… Read More

    Jan. 18, 2011

  • Vanderbilt University

    Video: VUCast: What is discovery science?

    Cancer researchers, led by investigators at Vanderbilt-Ingram Cancer Center, have identified two novel gene fusions in melanoma that may be responsive to existing cancer therapies. Melanoma is the most deadly form of skin cancer. From left, Jeffrey Sosman, M.D., doctoral candidate Katherine Hutchinson and William Pao, M.D.,… Read More

    Oct. 15, 2010